PATENT CLAIM ANALYSIS

Application Number: 15891802
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "141100"]

Abstract:
Methods for identifying compounds that positively regulate connexin 43 hemichannels.

Claim (Index 7):
An in vivo method of identifying an anti-metastatic compound comprising;\n (a) injecting labeled cancer cells into a model animal via the left ventricle of the heart; (b) administering a candidate hemichannels modulating compound to the animal; (c) imaging the labeled cancer cells; and (d) quantitating labeled cancer cells present in metastatic locations in the animal.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14912986', '11883739', '14404358', '15012732', '10353549']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6600476749525376
- 35 USC 102 Novelty (BERT): 0.6041949743843688
- Combined Prediction Score: 0.6544624048957207
- Mean Citation Score: 364.173404
- Max Citation Score: 641.90094
- Similarity Product: 442.86217653076886

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test